Induction of cGMP-mediated migraine attacks is independent of CGRP receptor activation
Cephalalgia · 2024
DOI: 10.1177/03331024241259489 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cephalalgia, 2024. Verfasst von Bianca Raffaelli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Danish Headache Center, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Sildenafil Citrate, Cross-Over Studies, Receptors, Calcitonin Gene-Related Peptide, Migraine Disorders. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Lundbeck Foundation, Deutsche Forschungsgemeinschaft, Novartis.
Abstract (Originalsprache)
Background
The cAMP and cGMP pathways are implicated in the initiation of migraine attacks, but their interactions remain unclear. Calcitonin gene-related peptide (CGRP) triggers migraine attacks via cAMP, whereas the phosphodiesterase-5 inhibitor sildenafil induces migraine attacks via cGMP. Our objective was to investigate whether sildenafil could induce migraine attacks in individuals with migraine pre-treated with the CGRP-receptor antibody erenumab.
Methods
In this randomized, double-blind, placebo-controlled, cross-over study, adults with migraine without aura received a single subcutaneous injection of 140 mg erenumab on day 1. They were then randomized to receive sildenafil 100 mg or placebo on two experimental days, each separated by at least one week, between days 8 and 21. The primary endpoint was the difference in the incidence of migraine attacks between sildenafil and placebo during the 12-h observation period after administration.
Results
In total, 16 participants completed the study. Ten participants (63%) experienced a migraine attack within 12 h after sildenafil administration compared to three (19%) after placebo ( p = 0.016). The median headache intensity was higher after sildenafil than after placebo (area under the curve (AUC) for the 12-h observation period, p = 0.026). Furthermore, sildenafil induced a significant decrease in mean arterial blood pressure (AUC, p = 0.026) and a simultaneous increase in heart rate (AUC, p < 0.001) during the first hour after administration compared to placebo.
Conclusion
These findings provide evidence that migraine induction via the cGMP pathway can occur even under CGRP receptor blockade.
Trial registration
ClinicalTrials.gov: Identifier NCT05889455.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Danish Headache Center, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany.
- Clinician Scientist Program, Berlin Institute of Health at Charité (BIH), Berlin, Germany.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Translational Research Center, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Novartis Pharma AG, Basel, Switzerland.
ORCID-Profile: Bianca Raffaelli, Thien Phu Do, Håkan Ashina
Förderung
- Lundbeck Foundation
- Deutsche Forschungsgemeinschaft
- Novartis
Zitieren
APA
Raffaelli, B., Do, T. P., Ashina, H., Snellman, J., Maio-Twofoot, T., & Ashina, M. (2024). Induction of cGMP-mediated migraine attacks is independent of CGRP receptor activation. Cephalalgia. https://doi.org/10.1177/03331024241259489
Vancouver
Raffaelli B, Do TP, Ashina H, Snellman J, Maio-Twofoot T, Ashina M. Induction of cGMP-mediated migraine attacks is independent of CGRP receptor activation. Cephalalgia. 2024. doi:10.1177/03331024241259489
BibTeX
@article{Raffaelli2024,
author = {Raffaelli, Bianca and Do, Thien Phu and Ashina, Håkan and Snellman, Josefin and Maio-Twofoot, Tina and Ashina, Messoud},
title = {Induction of cGMP-mediated migraine attacks is independent of CGRP receptor activation},
journal = {Cephalalgia},
year = {2024},
doi = {10.1177/03331024241259489}
}
EUVIMED